Internet-delivered Cognitive Behavioral Treatment of Depression and Anxiety in Latin American College Students
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04780542|
Recruitment Status : Recruiting
First Posted : March 3, 2021
Last Update Posted : April 27, 2021
|Condition or disease||Intervention/treatment||Phase|
|Major Depressive Disorder Generalized Anxiety Disorder||Behavioral: Yo Puedo Sentirme Bien- Clinician-Guided version Behavioral: Yo Puedo Sentirme Bien- Self-Guided version Behavioral: Treatment as usual||Not Applicable|
This study is designed to detect, engage, and experimentally evaluate the effects of internet-based cognitive behavior therapy (e-CBT) to treat college students in two Latin American low-middle income countries (LMICs; Colombia and Mexico) with major depressive disorder and/or generalized anxiety disorder, with or without other comorbid common mental disorders (CMDs). Detection and engagement will be based on inexpensive internet-based recruitment and administration of self-report surveys. The intervention will be based on inexpensive e-CBT to address the low resources in LMICs. The study builds on prior research by collaborators in the WHO World Mental Health (WMH) survey consortium and WMH International College Study (WMH-ICS) initiative documenting high prevalence, impairment, and unmet need for treatment of CMDs among college students around the world and significant effects of e-CBT in treating these disorders in high income countries.
First, the investigators will carry out a pragmatic clinical trial with students seeking treatment for CMDs at student clinics in universities in Colombia and Mexico. Students on waitlists for student clinic services will be offered a possibility of receiving guided or self-guided e-CBT immediately while staying on the list. 33% of the students with CMD who express interest will be randomized to guided e-CBT, another 33% to self-guided e-CBT, and the remaining 33% to treatment as usual (TAU), where the latter is defined as remaining on the waiting list. Short-term aggregate intervention effects will be assessed 90 days after randomization and longer-term effects 12 months after randomization. The investigators will then use ensemble machine learning methods to predict heterogeneity of treatment effects of e-CBT versus TAU and develop a precision treatment rule (PTR) to predict which students will respond best to which intervention. A SMART design will then be implemented in which 50% of a second cohort of students from the same sample frame (i.e., students seeking treatment for CMDs at student clinics in the participating universities) will be randomized to the treatment arm predicted to be optimal by the PTR and the other 50% to randomization across arms.
Additionally, the investigators will use outreach to recruit students into the trial who might not otherwise seek treatment from student clinics. Two procedures will be used here. In the first, students will be recruited from annual WMH-ICS internet-based mental health needs assessment surveys that will be carried out with a probability sample of students to estimate unmet need for treatment and barriers to treatment. Students who respond to these surveys and meet inclusion criteria and are not in treatment will be randomized to guided e-CBT, self-guided e-CBT, and treatment as usual in student clinics to determine if access to guided and self-guided e-CBT reduces the unmet need for treatment among students with CMDs who fail to seek treatment at student health clinics. The second will expand recruitment by sending emails to random subsamples of students notifying them of the availability of the internet-based interventions and inviting them to participate in a trial. Students that respond to this announcement will then be recruited and randomized into the same three arms as among students that participated in the annual WMH-ICS survey.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1500 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Masking Description:||Participant recruiters will be blinded to the participant's intended treatment arm.|
|Official Title:||Computerized Detection and Internet-based Treatment of Common Mental Disorders Among College Students in Two Latin American LMICs|
|Actual Study Start Date :||March 1, 2021|
|Estimated Primary Completion Date :||May 2025|
|Estimated Study Completion Date :||June 2025|
Experimental: Clinician-Guided iCBT
Both help-seeking students recruited from university clinics and non-help-seeking students recruited from needs assessment survey and outreach will receive internet delivered cognitive behavioral therapy guided by clinicians
Behavioral: Yo Puedo Sentirme Bien- Clinician-Guided version
Internet delivered Cognitive Behavioral Therapy- Guided version
Active Comparator: Treatment as usual
Help-seeking students recruited from university clinics will remain on waitlist until they receive treatment as usual. Non-help-seeking students recruited from needs assessment survey and outreach will be referred to university health clinic.
Behavioral: Treatment as usual
Waitlist until appointment and then treatment as usually provided by student clinic
Active Comparator: Self-guided iCBT
Help-seeking students recruited from university clinics will receive self-guided internet delivered cognitive behavioral therapy while on waitlist. Non-help seeking students recruited from needs assessment survey and outreach will receive the self-guided version of internet delivered cognitive behavioral therapy.
Behavioral: Yo Puedo Sentirme Bien- Self-Guided version
Internet delivered Cognitive Behavioral Therapy- Self-Guided version
- Patient Health Questionnaire-9 (PHQ-9) [ Time Frame: 90 days ]Self-report measure of depressive symptoms in the prior 2 weeks. Scores range from 0 to 27 with higher scores representing greater depressive symptomatology.
- Generalized Anxiety Disorder-7 (GAD-7) [ Time Frame: 90 days ]Self-report measure of anxiety symptoms in the prior 2 weeks. Scores range from 0 to 21 with higher scores representing greater anxiety.
- Patient Health Questionnaire-9 (PHQ-9) [ Time Frame: 12 months ]Self-report measure of depressive symptoms in the prior 2 weeks. Scores range from 0 to 27 with higher scores representing greater depressive symptomatology.
- Generalized Anxiety Disorder-7 (GAD-7) [ Time Frame: 12 months ]Self-report measure of anxiety symptoms in the prior 2 weeks. Scores range from 0 to 21 with higher scores representing greater anxiety.
- Sheehan Disability Scale (SDS) [ Time Frame: 90 days ]Self-report measure of impairment due to mental health in four life areas in the prior 2 weeks. Scores in each area range from 0 to 10 with higher scores reflecting greater impairment.
- Sheehan Disability Scale (SDS) [ Time Frame: 12 months ]Self-report measure of impairment due to mental health in four life areas in the prior 2 weeks. Scores in each area range from 0 to 10 with higher scores reflecting greater impairment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04780542
|Contact: Corina Benjet, PhDfirstname.lastname@example.org|
|Universidad Cooperativa de Colombia||Recruiting|
|Contact: Nayib Ester Carrasco Tapias, PhD email@example.com|
|Universidad Nacional Autonoma de México||Recruiting|
|Mexico City, Mexico|
|Contact: Benjamin Guerrero Lopez, MD firstname.lastname@example.org|
|Principal Investigator:||Corina Benjet, PhD||Instituto Nacional de Psiquiatría|